Immunotherapy works by enhancing the immune system's ability to recognize and destroy cancer cells. This can be achieved through various mechanisms, including inhibiting immune checkpoints, which are proteins that regulate the immune response, or engineering T-cells to target specific cancer cells. Epidemiologists study the populations that respond best to these treatments, which can inform personalized medicine approaches.
